Point72 Hong Kong Ltd - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 195 filers reported holding NEKTAR THERAPEUTICS in Q3 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2022$10,000
-89.4%
3,017
-42.5%
0.00%
-100.0%
Q3 2021$94,000
-65.4%
5,248
-66.9%
0.00%
-66.7%
Q2 2021$272,000
+13500.0%
15,849
+11553.7%
0.01%
Q4 2020$2,000
-99.6%
136
-99.4%
0.00%
-100.0%
Q2 2020$489,000
+270.5%
21,131
+192.6%
0.05%
+42.1%
Q3 2019$132,000
+1785.7%
7,222
+3212.8%
0.04%
+1166.7%
Q1 2019$7,000
-30.0%
218
+36.2%
0.00%0.0%
Q3 2018$10,000
-52.4%
160
-18.4%
0.00%
-72.7%
Q1 2018$21,000
+200.0%
196
-51.0%
0.01%
+175.0%
Q3 2016$7,0004000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2016
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders